Short Communication

You have free access to this content

Effect of the timing of food intake on the absorption and bioavailability of carbamazepine immediate-release tablets in beagle dogs

  1. Cai-hong Xu,
  2. Gang Cheng*,
  3. Yi Liu,
  4. Ye Tian,
  5. Jing Yan,
  6. Mei-juan Zou

Article first published online: 8 FEB 2012

DOI: 10.1002/bdd.1772

Issue

Biopharmaceutics & Drug Disposition

Biopharmaceutics & Drug Disposition

Volume 33, Issue 1, pages 30–38, January 2012

Additional Information

How to Cite

Xu, C.-h., Cheng, G., Liu, Y., Tian, Y., Yan, J. and Zou, M.-j. (2012), Effect of the timing of food intake on the absorption and bioavailability of carbamazepine immediate-release tablets in beagle dogs. Biopharm. Drug Dispos., 33: 30–38. doi: 10.1002/bdd.1772

Author Information

  1. Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, PR China

*Department of Pharmaceutics, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang 110016, Liaoning Province, PR China.
E-mail: Chenggang63@hotmail.com or xuch0828@hotmail.com

Publication History

  1. Issue published online: 7 MAR 2012
  2. Article first published online: 8 FEB 2012
  3. Accepted manuscript online: 23 JAN 2012 06:21AM EST
  4. Manuscript Accepted: 14 JAN 2012
  5. Manuscript Revised: 10 DEC 2011
  6. Manuscript Received: 8 SEP 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (136K)

References

  • 1
    Schmidt LE, Dalhoff K. Food–drug inteactions. Drugs 2002; 62: 1481–1502.
  • 2
    Fleisher D, Li C, Zhou YJ, Pao LH, Karim A. Drug, meal and formulation interactions influencing drug absorption after oral administration-clinical implications. Clin Pharmacokinet 1999; 36: 233–254.
  • 3
    Brouwers J, Tack J, Augustijns P. Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state. Pharm Res 2007; 24: 1862–1869.
  • 4
    Crevoisier C, Zerr P, Calvi-Gries F, Nilsen T. Effects of food on the pharmacokinetics of levodopa in a dual-release formulation. Eur J Pharm Biopharm 2003; 55: 71–76.
  • 5
    Schöffski P, Herr A, Vermorken JB, et al. Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer – significant effect of food intake on the bioavailability of the oral camptothecin analogue. Eur J Cancer 2002; 38: 807–813.
  • 6
    Woo JS, Song YK, Hong JY, Lim SJ, Kim CK. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. Eur J Pharm Sci 2008; 33: 159–165.
  • 7
    Meng X, Mojaverian P, Doedée M, et al. Bioavailability of amiodarone tablets administered with and without food in healthy subjects. Am J Cardiol 2001; 87: 432–435.
  • 8
    Cao QR, Cui JH, Park JB, et al. Effect of food components and dosing times on the oral pharmacokinetics of nifedipine in rats. Int J Pharm 2010; 396: 39–44.
  • 9
    Sunesen VH, Vedelsdal R, Kristensen HG, Chistrup L, Müllertz A. Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug. Eur J Pharm Sci 2005; 24: 297–303.
  • 10
    Laitinen K, Patronen A, Harju P, et al. Timing of food intake has a marked effect on the bioavailability of clodronate. Bone 2000; 27: 293–296.
  • 11
    Olling M, Mensinga TT, Barends DM, Groen C, Lake OA, Meulenbelt J. Bioavailability of carbamazepine from four different products and the occurrence of side effects. Biopharm Drug Dispos 1999; 20: 19–28.
    Direct Link:
  • 12
    Lee H, Park SA, Sah H. Surfactant effects upon dissolution patterns of carbamazepine immediate release tablet. Arch Pharm Res 2005; 28: 120–126.
  • 13
    Torbjörn T. Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinet 1987; 3: 128–132.
  • 14
    Kahela P, Aaltoen R, Lewing E, Anttila M, Kristoffersson E. Pharmacokinetics and dissolution of two crystalline forms of carbamazepine. Int J Pharm 1983; 14: 103–120.
  • 15
    Jung H, Milán R, Girard ME, León F, Montoya MA. Bioequivalence study of carbamazepine tablets: In vitro–in vivo correlation. Int J Pharm 1997; 152: 37–44.
  • 16
    Retzow A, Schürer M, Schulz HU. Influence of food on the bioavailability of a carbamazepine slow-release formulation. Int J Clin Pharmacol Ther 1997; 35: 557–560.
  • 17
    McLean A, Browne S, Zhang Y, Slaughter E, Halstenson C, Couch R. The influence of food on the bioavailability of a twice-daily controlled release carbamazepine formulation. J Clin Pharmacol 2001; 41: 183–187.
  • 18
    Assion HJ, Werner U, Theisohn M. Influence of meals on the bioavailability and side effects of carbamazepine. Eur Psychiat 1996; 11: 333s.
  • 19
    Levy RH, Pitlick WH, Troupin AS, Green JR, Neal JM. Pharmacokinetics of carbamazepine in normal man. Clin Pharmacol Ther 1975; 17: 657–668.
  • 20
    Malhotra S, Dixit RK, Garg SK. Effect of an acidic beverage (Coca-Cola) on the pharmacokinetics of carbamazepine in healthy volunteers. Methods Find Exp Clin Pharmacol 2002; 24: 31–33.
  • 21
    Garg SK, Kumar N, Bhargava VR, Prabhakar SK. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther 1998; 64: 286–288.
  • 22
    Lake OA, Olling M, Barends DM. In vitro in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers. Eur J Pharm Biopharm 1999; 48: 13–19.
  • 23
    Dressman JB. Comparison of canine and human gastrointestinal physiology. Pharm Res 1986; 3: 123–131.
  • 24
    Lui CY, Amidon GL, Berardi RR, Fleisher D, Youngberg C, Dressman JB. Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans. J Pharm Sci 1986; 75: 271–274.
    Direct Link:
  • 25
    Wu Y, Loper A, Landis E, et al. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. Int J Pharm 2004; 285: 135–146.
  • 26
    Ward KW, Nagilla R, Jolivette LJ. Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human. Xenobiotica 2005; 35: 191–210.
  • 27
    Kobayashi Y, Ito S, Itai S, Yamamoto K. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int J Pharm 2000; 193: 137–146.
  • 28
    Steel RG, Torrie JH. Principles and Procedures of Statistics. A Biometrical Approach (2nd edn). McGraw-Hill: New York, 1980.
  • 29
    Gérardin AP, Abadie FV, Campestrini JA, Theobald W. Pharmacokinetics of carbamazepine in normal humans after single and repeated oral doses. J Pharm Biopharm 1976; 4: 521–535.
  • 30
    Winnicka RI, Łopaciński B, Szymczak WM, Szymańska B. Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide. Clin Toxicol 2002; 40: 759–765.
  • 31
    Sugano K, Kataoka M, Mathews CC, Yamashita S. Prediction of food effect by bile micelles on oral drug absorption considering free fraction in intestinal fluid. Eur J Pharm Sci 2010; 40: 118–124.
  • 32
    Wilding IR, Davis SS, Hardy JG, et al. Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N labeled drug to healthy volunteers. Br J Clin Pharmacol 1991; 32: 573–579.
  • 33
    Fleischman A, Chiang VW. Carbamazepine overdose recognized by a tricyclic antidepressant assay. Pediatrics 2001; 107: 176–177.
  • 34
    Alexishvili MM, Rukhadze MD, Okujava VM. Simultaneous determination of carbamazepine and carbamazepine 10,11-epoxide by using microcolumn HPLC: study of pharmacokinetics of carbamazepine in a volunteer. Biomed Chromatogr 1997; 11: 36–41.
    Direct Link:
  • 35
    Sutton SC. Companion animal physiology and dosage form performance. Adv Drug Deliv Rev 2004; 56: 1383–1398.
  • 36
    Lentz KA. Current methods for predicting human food effect. AAPS J 2008; 10: 282–288.
  • 37
    Paulson SK, Vaughn MB, Jessen SM, et al. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J Pharmacol Exp Ther 2001; 297: 638–645.
View Full Article (HTML) Get PDF (136K)